Nisha Chhabria MD, FAAN’s Post

View profile for Nisha Chhabria MD, FAAN, graphic

Medical Director, Clinical Development CNS Gene Therapy

More exciting news from my team!

We’re excited to share that AB-1005, which is being developed for moderate Parkinson’s disease, received US FDA Fast Track and UK MHRA Innovation Passport designations. There's a huge unmet need for #Parkinson's treatment, and these designations take us another step closer to accelerating access for patients. We at #AskBio, alongside Bayer | Pharmaceuticals, are dedicated to providing patients with innovative therapies and, most importantly, improving patient outcomes. #genetherapy   For Medical Media – Read our press release here: https://lnkd.in/g7Mr854f  

  • No alternative text description for this image

Tremendous! Congratulations - this is great news.

To view or add a comment, sign in

Explore topics